NAT-BENDAMUSTINE

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 1df9e20fc9cfb72e
Drug Approval Canada Name: NAT-BENDAMUSTINE
Product Name: NAT-BENDAMUSTINE
Status: Marketed
Status Date: 2021-02-25
Original Market Date: 2021-02-25
Din: 02496887
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01AA09 BENDAMUSTINE
Atc Name: l 01 aa 09
Aig Number: 0153268001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

BENDAMUSTINE HYDROCHLORIDE

25 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1df9e20fc9cfb72e

Type

Standard